Cytotoxic drugs studied in this study and their indications
| Drug | Major Indication |
|---|---|
| Doxorubicin | Lymphomas |
| Breast cancer | |
| Sarcomas | |
| Hepatocellular cancer | |
| Leukaemias | |
| Epirubicin | Breast cancer |
| Hepatocellular cancer | |
| Daunorubicin | Acute myelogenous leukemia |
| Acute lymphocytic leukemia | |
| Idarubicin | Acute myelogenous leukemia |
| Etoposide | Testicular cancer |
| Small cell lung cancer | |
| Ovarian cancer | |
| Irinotecan (SN-38) | Colorectal cancer |
| Pancreatic cancer | |
| Ovarian cancer | |
| Topotecan | Small cell lung cancer |
| Ovarian cancer | |
| Lung cancer | |
| 5-FU | Colorectal cancer |
| Breast cancer | |
| Ovarian cancer | |
| Hepatocellular cancer | |
| Stomach cancer | |
| Pancreatic cancer | |
| Camptothecin | Not approved for clinical use |
| Mitomycin C | Hepatocellular cancer |
| Stomach cancer | |
| Pancreatic cancer | |
| Colon cancer | |
| Breast cancer | |
| Anal cancer | |
| Lung cancer |